Healthcare Sales & Marketing Network News: erythropoietin receptor activator

Searching News Database: erythropoietin receptor activator

HSMN NewsFeed - 19 Oct 2007
Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks
Biopharmaceuticals

HSMN NewsFeed - 15 Dec 2006
Roche Offers the FDA Additional MIRCERA(R) Data
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2006
C.E.R.A. Administered Up to Once Every Four Weeks Maintained Stable Hemoglobin Levels in Dialysis Patients with Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 20 Oct 2006
U.S. Court Begins Discovery Phase in Patent Infringement Suit
Biopharmaceuticals Litigation

HSMN NewsFeed - 16 Jul 2006
C.E.R.A. Anti-Anemia Drug Maintained Stable Hemoglobin Levels in Dialysis Patients With Up to Once Every Four Week Dosing in Phase III Clinical Studies
Biopharmaceuticals

Return to NewsFeed

Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 4 additional stories matching:
erythropoietin receptor activator
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.